222 related articles for article (PubMed ID: 10825143)
1. Methioninase gene therapy of human cancer cells is synergistic with recombinant methioninase treatment.
Miki K; Al-Refaie W; Xu M; Jiang P; Tan Y; Bouvet M; Zhao M; Gupta A; Chishima T; Shimada H; Makuuchi M; Moossa AR; Hoffman RM
Cancer Res; 2000 May; 60(10):2696-702. PubMed ID: 10825143
[TBL] [Abstract][Full Text] [Related]
2. Survival efficacy of the combination of the methioninase gene and methioninase in a lung cancer orthotopic model.
Miki K; Xu M; An Z; Wang X; Yang M; Al-Refaie W; Sun X; Baranov E; Tan Y; Chishima T; Shimada H; Moossa AR; Hoffman RM
Cancer Gene Ther; 2000 Feb; 7(2):332-8. PubMed ID: 10770644
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
[TBL] [Abstract][Full Text] [Related]
4. Polyethylene glycol conjugation of recombinant methioninase for cancer therapy.
Tan Y; Sun X; Xu M; An Z; Tan X; Han Q; Miljkovic DA; Yang M; Hoffman RM
Protein Expr Purif; 1998 Feb; 12(1):45-52. PubMed ID: 9473456
[TBL] [Abstract][Full Text] [Related]
5. Methioninase Gene Therapy.
Hoffman RM; Miki K; Al-Refaie W; Xu M; Tan Y
Methods Mol Biol; 2019; 1866():173-197. PubMed ID: 30725416
[TBL] [Abstract][Full Text] [Related]
6. Anticancer efficacy in vivo and in vitro, synergy with 5-fluorouracil, and safety of recombinant methioninase.
Yoshioka T; Wada T; Uchida N; Maki H; Yoshida H; Ide N; Kasai H; Hojo K; Shono K; Maekawa R; Yagi S; Hoffman RM; Sugita K
Cancer Res; 1998 Jun; 58(12):2583-7. PubMed ID: 9635582
[TBL] [Abstract][Full Text] [Related]
7. Overexpression and large-scale production of recombinant L-methionine-alpha-deamino-gamma-mercaptomethane-lyase for novel anticancer therapy.
Tan Y; Xu M; Tan X; Tan X; Wang X; Saikawa Y; Nagahama T; Sun X; Lenz M; Hoffman RM
Protein Expr Purif; 1997 Mar; 9(2):233-45. PubMed ID: 9056489
[TBL] [Abstract][Full Text] [Related]
8. Recombinant methioninase infusion reduces the biochemical endpoint of serum methionine with minimal toxicity in high-stage cancer patients.
Tan Y; Zavala J; Han Q; Xu M; Sun X; Tan X; Tan X; Magana R; Geller J; Hoffman RM
Anticancer Res; 1997; 17(5B):3857-60. PubMed ID: 9427792
[TBL] [Abstract][Full Text] [Related]
9. Combination efficacy of doxorubicin and adenoviral methioninase gene therapy with prodrug selenomethionine.
Gupta A; Miki K; Xu M; Yamamoto N; Moossa AR; Hoffman RM
Anticancer Res; 2003; 23(2B):1181-8. PubMed ID: 12820369
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cancer cells with methioninase produces DNA hypomethylation and increases DNA synthesis.
Machover D; Zittoun J; Saffroy R; Broët P; Giraudier S; Magnaldo T; Goldschmidt E; Debuire B; Orrico M; Tan Y; Mishal Z; Chevallier O; Tonetti C; Jouault H; Ulusakarya A; Tanguy ML; Metzger G; Hoffman RM
Cancer Res; 2002 Aug; 62(16):4685-9. PubMed ID: 12183426
[TBL] [Abstract][Full Text] [Related]
11. DNA-Binding Agent Trabectedin Combined With Recombinant Methioninase Is Synergistic to Decrease Fibrosarcoma Cell Viability and Induce Nuclear Fragmentation But Not Synergistic on Normal Fibroblasts.
Morinaga S; Han Q; Kubota Y; Mizuta K; Kang BM; Sato M; Bouvet M; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Higuchi T; Tsuchiya H; Demura S; Hoffman RM
Anticancer Res; 2024 Jun; 44(6):2359-2367. PubMed ID: 38821601
[TBL] [Abstract][Full Text] [Related]
12. Circulating half-life of PEGylated recombinant methioninase holoenzyme is highly dose dependent on cofactor pyridoxal-5'-phosphate.
Yang Z; Sun X; Li S; Tan Y; Wang X; Zhang N; Yagi S; Takakura T; Kobayashi Y; Takimoto A; Yoshioka T; Suginaka A; Frenkel EP; Hoffman RM
Cancer Res; 2004 Aug; 64(16):5775-8. PubMed ID: 15313919
[TBL] [Abstract][Full Text] [Related]
13. Broad selective efficacy of rMETase and PEG-rMETase on cancer cells in vitro.
Tan Y; Xu M; Hoffman RM
Anticancer Res; 2010 Mar; 30(3):793-8. PubMed ID: 20392998
[TBL] [Abstract][Full Text] [Related]
14. Extensive Synergy Between Recombinant Methioninase and Eribulin Against Fibrosarcoma Cells But Not Normal Fibroblasts.
Morinaga S; Han Q; Kubota Y; Mizuta K; Kang BM; Sato M; Bouvet M; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Higuchi T; Tsuchiya H; Hoffman RM
Anticancer Res; 2024 Mar; 44(3):921-928. PubMed ID: 38423656
[TBL] [Abstract][Full Text] [Related]
15. Development of Recombinant Methioninase for Cancer Treatment.
Hoffman RM; Tan Y; Li S; Han Q; Yagi S; Takakura T; Takimoto A; Inagaki K; Kudou D
Methods Mol Biol; 2019; 1866():107-131. PubMed ID: 30725412
[TBL] [Abstract][Full Text] [Related]
16. In vivo efficacy of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5'-phosphate supplementation.
Sun X; Yang Z; Li S; Tan Y; Zhang N; Wang X; Yagi S; Yoshioka T; Takimoto A; Mitsushima K; Suginaka A; Frenkel EP; Hoffman RM
Cancer Res; 2003 Dec; 63(23):8377-83. PubMed ID: 14678999
[TBL] [Abstract][Full Text] [Related]
17. PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates.
Yang Z; Wang J; Lu Q; Xu J; Kobayashi Y; Takakura T; Takimoto A; Yoshioka T; Lian C; Chen C; Zhang D; Zhang Y; Li S; Sun X; Tan Y; Yagi S; Frenkel EP; Hoffman RM
Cancer Res; 2004 Sep; 64(18):6673-8. PubMed ID: 15374983
[TBL] [Abstract][Full Text] [Related]
18. Development of recombinant methioninase to target the general cancer-specific metabolic defect of methionine dependence: a 40-year odyssey.
Hoffman RM
Expert Opin Biol Ther; 2015 Jan; 15(1):21-31. PubMed ID: 25439528
[TBL] [Abstract][Full Text] [Related]
19. Broad selective efficacy of recombinant methioninase and polyethylene glycol-modified recombinant methioninase on cancer cells In Vitro.
Tan Y; Xu M; Hoffman RM
Anticancer Res; 2010 Apr; 30(4):1041-6. PubMed ID: 20530407
[TBL] [Abstract][Full Text] [Related]
20. Effective Metabolic Targeting of Human Osteosarcoma Cells
Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Murakami T; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Hoffman RM
Anticancer Res; 2017 Sep; 37(9):4807-4812. PubMed ID: 28870899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]